Evidence map›Paper›PMID 30823439›Full record

ArticleMolecules (Basel, Switzerland)2019

Using UHPLC-MS Profiling for the Discovery of New Dihydro-β-Agarofurans from Australian Celastraceae Plant Extracts.

Mario Wibowo, Paul I Forster, Gordon P Guymer, Andreas Hofmann, Rohan A Davis

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Australian Rainforests-A Living Museum of Natural Product Chemical Diversity.Progress in the chemistry of organic natural products · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mario WibowoGriffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia. mario.wibowo@griffithuni.edu.au.ORCID 0000-0002-5739-0949
Paul I ForsterQueensland Herbarium, Brisbane Botanic Gardens, Toowong, QLD 4066, Australia. paul.forster@des.qld.gov.au.
Gordon P GuymerQueensland Herbarium, Brisbane Botanic Gardens, Toowong, QLD 4066, Australia. gordon.guymer@des.qld.gov.au.
Andreas HofmannGriffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia. a.hofmann@griffith.edu.au.
Rohan A DavisGriffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia. r.davis@griffith.edu.au.ORCID 0000-0003-4291-7573
Griffith University · AU

Funding

Australian Research Council LE0668477, LE140100119, and LE0237908
6 · The paper itself

Abstract

An analytical method using UHPLC-MS was developed and applied to 16 crude CH₂Cl₂ extracts from Australian Celastraceae plants; the endemic plant materials were accessed from Griffith University's NatureBank resource and included bark, fruit, leaf, root, twig and mixed samples, all of which were collected from Queensland, Australia. The generated UHPLC-MS data were analysed and dereplicated using the scientific databases Dictionary of Natural Products and SciFinder Scholar in order to potentially identify new dihydro-β-agarofurans from local Celastraceae plants. These investigations led to the large-scale extraction and isolation work on a prioritised fruit sample that belonged to the rainforest plant

Indexed as

AustraliaCelastraceaeChromatography, High Pressure LiquidMass SpectrometryPlant ExtractsRainforestSesquiterpenesdihydroagarofuranPlant ExtractsSesquiterpenesCelastraceaeDenhamia celastroidesdihydro-β-agarofuranNMRsesquiterpenoidUHPLC-MS

Identifiers

PMID30823439
PMCPMC6429220
OpenAlexW2916074325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.